Remifentanil Hydrochloride Injection, Powder, Lyophilized, For Solution
Product Images NDC 0143-9392

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Remifentanil Hydrochloride (NDC 0143-9392). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (0bc4c167 59ce 43ad 9db8 281e4a166887 01)

Chemical structure of Remifentanil Hydrochloride, showing its molecular framework including ester groups, a piperidine ring, and phenyl moieties consistent with this opioid analgesic compound.*

FDA Label Image

Image (0bc4c167 59ce 43ad 9db8 281e4a166887 02)

A line graph comparing minute ventilation as a percentage of baseline over time (in minutes) for Remifentanil Hydrochloride injection (n=11) and Alfentanil (n=10). The x-axis ranges from -30 to 270 minutes, covering during and post infusion periods. Data points show respiratory depression effects, with Remifentanil causing a sharper increase post infusion compared to Alfentanil.*

FDA Label Image

Image (0bc4c167 59ce 43ad 9db8 281e4a166887 03)

A line graph displaying mean concentration (ng/mL) on a logarithmic scale over time (minutes) with standard deviation (sd) error bars. It compares alfentanil at 0.5 mcg/kg/min and remifentanil hydrochloride injection at 0.05 mcg/kg/min, showing concentration changes over approximately 480 minutes.*

FDA Label Image

1 mg Vial (0bc4c167 59ce 43ad 9db8 281e4a166887 04)

Label for Remifentanil Hydrochloride for Injection 1 mg single dose vial. The product is sterile and intended for intravenous use only. Instructions note it must be reconstituted and diluted before use. The label indicates distribution by Hikma Pharmaceuticals USA Inc. and includes an NDC code 0143-9391-01.*

FDA Label Image

2mg Vial (0bc4c167 59ce 43ad 9db8 281e4a166887 05)

Label for Remifentanil Hydrochloride Injection 2 mg single dose vial by Hikma Pharmaceuticals USA Inc. The label states intravenous use only, that the product is sterile, must be reconstituted and diluted before use, and unused portions should be discarded. It includes an NDC number 0143-9392-01 and prompts to see the insert for usual dosage.*

FDA Label Image

5mg Vial (0bc4c167 59ce 43ad 9db8 281e4a166887 06)

Label for Remifentanil Hydrochloride for Injection, 5 mg strength, lyophilized powder for intravenous use. The single-dose vial is labeled with directions to reconstitute and dilute before use. Distributed by Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ. Contains 5 mg per vial and is Rx only.*

FDA Label Image

1 mg Carton (0bc4c167 59ce 43ad 9db8 281e4a166887 07)

Remifentanil Hydrochloride 1 mg injection powder, lyophilized, for intravenous use only, in single-dose vials. The label shows the product name, strength (1 mg), usage directions, storage instructions, and distribution by Hikma Pharmaceuticals USA Inc. It indicates that each vial contains an equivalent of 1 mg of remifentanil, with 10 single-dose vials per package.*

FDA Label Image

2 mg Carton (0bc4c167 59ce 43ad 9db8 281e4a166887 08)

Remifentanil Hydrochloride for Injection 2 mg lyophilized powder vial carton label by Hikma Pharmaceuticals USA Inc. The label states it is for intravenous use only and contains a single 2 mg dose vial for reconstitution. It includes dosage information and the NDC 0143-9392-10.*

FDA Label Image

5 mg Carton (0bc4c167 59ce 43ad 9db8 281e4a166887 09)

Packaging label for Remifentanil Hydrochloride Injection 5 mg, lyophilized powder for solution, for intravenous use only. The label indicates the product is equivalent to 5 mg of remifentanil, comes as a single-dose vial, and is manufactured by Hikma Pharmaceuticals USA Inc. It includes storage instructions and dosage details on the label panels.*

FDA Label Image

Serialization Image (0bc4c167 59ce 43ad 9db8 281e4a166887 10)

Remifentanil Hydrochloride vial label with text fields for GTIN, lot number, expiration date, and serial number, along with a Data Matrix barcode. The label is intended for the lyophilized powder injection form for intravenous use by Hikma Pharmaceuticals USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.